{
    "clinical_study": {
        "@rank": "20152", 
        "arm_group": [
            {
                "arm_group_label": "1064nm laser Treatment Before Abdominoplasty", 
                "arm_group_type": "Experimental", 
                "description": "Patient will be treated with 1064nm Laser prior to abdominoplasty"
            }, 
            {
                "arm_group_label": "940nm Laser Treatment Before Abdominoplasty", 
                "arm_group_type": "Experimental", 
                "description": "Patient will be treated with 940nm Laser prior to abdominoplasty"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate and compare the safety and efficacy of a\n      non-invasive 1064nm  laser and 940nm diode, for the disruption of subcutaneous adipose\n      tissue and skin tightening."
        }, 
        "brief_title": "Evaluation of the Safety and Efficacy of a Non-Invasive Disruption of Fat and Skin Tightening Using 1064nm and 940nm Wavelengths", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Subcutaneous Fat", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Non-smoking subjects between ages of 20-55 years of age presenting excess abdominal\n             tissue (fat and skin), are candidates for an abdominoplasty procedure and are willing\n             to allow the use of this device on their skin\n\n          -  Subjects (Group 2 and 3) who will allow the excess skin removed as part of the\n             abdominoplasty to be sent for laboratory analysis\n\n          -  Understand and accept the obligation associated with the procedure\n\n          -  Subjects with Fitzpatrick skin types I to VI.\n\n          -  Subjects (Group 2 and 3) who are willing to consent to participate in the study will\n             be asked to undergo treatment, elasticity and ultrasound measurements, as outlined\n             for each group and defined in section 6.0.\n\n          -  Subjects must agree to maintain the same diet and exercise regime throughout the\n             study\n\n        Exclusion Criteria:\n\n          -  Any previous liposuction/lipo-sculpture or any type of procedure in the abdominal\n             area in the past 6 months\n\n          -  A history of allergic reactions to medications or anesthesia required for the\n             procedure\n\n          -  A history of thrombophlebitis\n\n          -  A history of acute infections\n\n          -  A history of heart failure\n\n          -  Received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics,\n             vitamin E or anti-inflammatories within 2 weeks pre treatment\n\n          -  Intolerance to anesthesia or medications to be prescribed before or after the\n             procedure.\n\n          -  Any medical condition, that, in the investigator's opinion would interfere with the\n             patient's participation in the study\n\n          -  Taking medications that are photosensitive\n\n          -  A history of keloid formation\n\n          -  A study subject must not be pregnant or have been pregnant in the last 3 months\n\n          -  The physician has the right to make determination of eligibility as he/she determines\n             based on the standard of care"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "11", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02098811", 
            "org_study_id": "CYN13-NIF-JD-04"
        }, 
        "intervention": [
            {
                "arm_group_label": "1064nm laser Treatment Before Abdominoplasty", 
                "description": "Patient will be treated with 1064nm Laser prior to abdominoplasty", 
                "intervention_name": "1064nm Laser", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "940nm Laser Treatment Before Abdominoplasty", 
                "description": "Patient will be treated with 940nm Laser prior to abdominoplasty", 
                "intervention_name": "940nm Laser", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 25, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Staten Island", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "103206"
                }, 
                "name": "Aesthetic Pavilion"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of the Safety and Efficacy of a Non-Invasive Disruption of Fat and Skin Tightening Using 1064nm and 940nm Wavelengths", 
        "overall_official": {
            "affiliation": "Cynosure, Inc.", 
            "last_name": "Patric Krantz", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Biopsy of treated area will be obtained up to 6 months post treatment and will be histologically assessed for changes in adipocytes, collagen and surrounding tissue to determine effectiveness of device", 
                "measure": "Biopsy of Tissue Sample as a Measure of Effectiveness", 
                "safety_issue": "Yes", 
                "time_frame": "6 months post treatment"
            }, 
            {
                "description": "Ultrasound of the treatment area will be performed and evaluated in comparison to the baseline results to determine reduction of fat", 
                "measure": "Ultrasound Measurement to Evaluate Reduction of Fat", 
                "safety_issue": "No", 
                "time_frame": "6 months post treatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02098811"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "High frequency ultrasound of the treatment area will be performed and evaluated in comparison to baseline results to measure changes in skin elasticity  and skin thickness.", 
            "measure": "High Frequency Ultrasound  to Measure Skin Elasticity and Thickness", 
            "safety_issue": "No", 
            "time_frame": "6 months post last treatment"
        }, 
        "source": "Cynosure, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cynosure, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}